Skip to main content
SpringerLink
Log in

Kontrolliertes Zuwarten

  • Chapter
Benigne Prostatahyperplasie

  • 64 Accesses

Zusammenfassung

Kontrolliertes Zuwarten (watchful waiting, WW) ist eine Strategie, bei der der Arzt den Patienten ohne aktive Therapie beobachtet. WW ist zwar die häufigste Behandlungsstrategie für Patienten mit leichten bis mäßigen Beschwerden, es ist aber wenig über WW als mögliche Therapieform bekannt. Das gleiche gilt für das Placebophänomen nach vorgetäuschter Behandlung, wobei u. E. ein differenter Wirkmechanismus vorliegt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abrams PH (1977) Prostatism and prostatectomy: the value of urine flow rate measurement in the preoperative assessement for operation. J Urol 117: 70–71

    PubMed  CAS  Google Scholar 

  2. Abrams P (1994) New words for old: lower urinary tract symptoms for »prostatism«. Brit Med J 308: 929

    PubMed  CAS  Google Scholar 

  3. Abrams P (1994) In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology 44:153

    Article  PubMed  CAS  Google Scholar 

  4. Arrighi HM, Metter EJ, Guess HA et al. (1991) Natural history of benighn prostatic hyperplasia and risk of prostatectomy. Urology 38: 4–8

    Article  PubMed  CAS  Google Scholar 

  5. Aso Y, Boccon-Gibod L, Brendler CB et al. (1993) Clinical research criteria. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G Proceedings of the 2nd international consultation on benign prostatic hyperplasia (BPH). Jersey, United Kingdom, Scientific Communication International Ltd, pp 343–359

    Google Scholar 

  6. Ballard D, Bryant S, O’Brien P et al. (1994) Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence? Health Serv Res 28: 771–784

    PubMed  CAS  Google Scholar 

  7. Barham CP, Pocock RD, James ED (1993) Who needs a prostatectomy? Review of a waiting list. Br JUrol 72:314–317

    CAS  Google Scholar 

  8. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human prostatic hyperplasia with age. J Urol 132: 474–479

    PubMed  CAS  Google Scholar 

  9. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM (1993) The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150: 85

    PubMed  CAS  Google Scholar 

  10. Craigen AA, Hickling JB, Saunders CR et al. (1969) Natural history of prostatic obstruction. JR Coli Gen Pract 18: 226–232

    CAS  Google Scholar 

  11. Ellenberg J, Nelson K (1980) Sample selection and the natural history of desease -studies of febrile seizures. JAMA 243:1337–1340

    Article  PubMed  CAS  Google Scholar 

  12. Ezz El Din K, Kiemeney LALM, de Wildt MJAM, Rosier PFWM, Debruyne FMJ, de la Rosette JJMCH (1996) The correlation between bladder outlet obstruction and lower urinary symptoms as measured by the international prostate symptom score. J Urol 156:1020–1025

    Article  Google Scholar 

  13. Garraway WM, Collins GN, Lee RJ (1991) High prevalence of benign prostatic hypertrophy in the Community. The Lancet 338:469–471

    Article  CAS  Google Scholar 

  14. Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O’Leary MP, Painter MR (1995) Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. JUrol 154: 205–206

    CAS  Google Scholar 

  15. George NJ, Feneley RC, Roberts JB (1986) Identification of the poor risk patient with prostatism and detrusor failure. Br J Urol 58: 290

    Article  PubMed  CAS  Google Scholar 

  16. Jensen KME (1989) Clinical evaluation of routine urodynamic investigations of prostatism. Neurourol Urodyn 8: 545–578

    Article  Google Scholar 

  17. Jensen KME, Jorgensen JB, Mogensen P (1988) Urodynamics in prostatism 1. Prognostic value of uroflowmetry. Scan J Urol Nephrol 22:109–117

    CAS  Google Scholar 

  18. Kadow C, Fenely RCL, Abrams PH (1988) Prostatectomy or conservative management in the treatment of benign prostatic hypertrophy? Br J Urol 61:432–434

    Article  PubMed  CAS  Google Scholar 

  19. Lepor H, Machi G (1993) Comparison of the AUA symptom index in unselected males and females between 55 and 79 years of age. Urology 42:36–40

    Article  PubMed  CAS  Google Scholar 

  20. McConnell JD (1994) Why pressure-flow studies should be optional and not mandatory in studies evaluating men with benign prostatic hyperplasia. Urology 44:156–158

    Article  PubMed  CAS  Google Scholar 

  21. McConnel JD, Barry MJ, Bruskewitz RC ETAL Etal (eds) (1994) Benign prostatic hyperplasia: diagnosis and treatment. Clinical practice guideline. Rockville, Maryland. US Department of Health and Human Services, Agency for Health Care Policy and Research

    Google Scholar 

  22. Mebust W, Hottgrewe H, Cockett A et al. (1989) Transurethal prostatectomy: immediate and postoperative complications. A comparative study of 13 participating institutions evaluating 3,885 patients. J Urol 141:243–347

    PubMed  CAS  Google Scholar 

  23. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P (1995) Impact of symptoms of prostatism on level of bother and quality of life of men in the French Community. J Urol 153: 669–673

    Article  PubMed  CAS  Google Scholar 

  24. le Schäfer W, Noppney R, Rübben H, Lutzeyer W (1988) The value of free flow rate and pressure flow-studies in the routine investigation of patients. Neurourol Urodyn 7:219

    Google Scholar 

  25. Tubaro A, Carter S, de la Rosette J et al. (1995) The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study. J Urol 153:1526–1530

    Article  PubMed  CAS  Google Scholar 

  26. Wasson JH, Reda DJ, Bruskewitz RC et al. (1995) Comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 332: 75–79

    Article  PubMed  CAS  Google Scholar 

  27. Witjes WPJ, de Wildt MJAM, Rosier PFWM, Caris CTM, Debruyne FMJ, de la Rosette JJMCH (1996) Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement. J Urol 156: 1026–1034

    Article  PubMed  CAS  Google Scholar 

  28. Witjes WP, Robertson A, Rosier PFWM, Neal DE, Debruyne FMJ, de la Rosette JJMCH (1997) Urodynamic and clinical effects of non-invasive and minimally invasive treatments in elderly males with lower urinary tract symptoms stratified according to the grade of obstruction. Urology 50: 55–61

    Article  PubMed  CAS  Google Scholar 

  29. Witjes WPJ, de la Rosette JJMCH, Donovan JL, Peters TJ, Kay HE, Höfner K, Kinn AC, Walter S and the ICS-BPH Study Group (1997) The ICS-BPH Study: international differences in lower urinary tract symptoms and related bother. J Urol 157:1295–1300

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. J. de la Rosette
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. M. Debruyne
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Urologische Klinik, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

    Klaus Höfner , Udo Jonas  & Christian G. Stief ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

de la Rosette, J.J., Debruyne, F.M. (2000). Kontrolliertes Zuwarten. In: Höfner, K., Jonas, U., Stief, C.G. (eds) Benigne Prostatahyperplasie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59580-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59580-6_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64034-6

  • Online ISBN: 978-3-642-59580-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation